Esophageal Cancer Stage III
4 clinical trials · Condition
◉ Watch Esophageal Cancer Stage III
| Record | Firm | Date |
|---|---|---|
| The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC (NCT06965829) | Shanghai Chest Hospital | 2025-07-01 |
| Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC (NCT03366883) | Tianjin Medical University Cancer Institute and Hospital | 2018-02-01 |
| PDL-1 Targeting in Resectable Oesophageal Cancer (NCT03087864) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2017-06-28 |
| FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer (NCT00578201) | Assistance Publique - Hôpitaux de Paris | 2007-11-01 |
Track Esophageal Cancer Stage III automatically
Every clearance here is in the API, with alerts when new ones post.